Smith & Nephew plc (LON:SN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Smith & Nephew plc (LON:SN - Get Free Report) has received an average recommendation of "Moderate Buy" from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is GBX 1,346.20 ($16.91).

Several research analysts have recently weighed in on SN shares. Barclays reissued an "equal weight" rating and issued a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a research report on Friday, February 9th. Berenberg Bank reaffirmed a "buy" rating and set a GBX 1,450 ($18.21) price objective on shares of Smith & Nephew in a research report on Thursday. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 1,250 ($15.70) price objective on shares of Smith & Nephew in a research report on Friday. Royal Bank of Canada reaffirmed an "outperform" rating and set a GBX 1,500 ($18.84) price objective on shares of Smith & Nephew in a research report on Friday, April 5th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the company an "overweight" rating in a research report on Thursday.

Smith & Nephew Price Performance

Shares of SN traded up GBX 9 ($0.11) during mid-day trading on Friday, hitting GBX 985.60 ($12.38). The company's stock had a trading volume of 2,907,511 shares, compared to its average volume of 343,671. The firm has a 50-day moving average price of GBX 1,021.40 and a 200 day moving average price of GBX 1,034.26. The stock has a market capitalization of £8.62 billion, a price-to-earnings ratio of 4,106.67, a PEG ratio of 0.46 and a beta of 0.51. The company has a debt-to-equity ratio of 59.11, a current ratio of 1.77 and a quick ratio of 0.84. Smith & Nephew has a fifty-two week low of GBX 887 ($11.14) and a fifty-two week high of GBX 1,316.75 ($16.54).

Smith & Nephew Increases Dividend

The business also recently announced a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be given a dividend of $0.23 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a yield of 1.62%. This is a positive change from Smith & Nephew's previous dividend of $0.14. Smith & Nephew's payout ratio is 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.